Study to Compare and evaluate better glycemic control in diabetic and non-diabetic patients.
- Registration Number
- CTRI/2019/11/021946
- Lead Sponsor
- Bangalore Diabetes Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Type II Diabetes Mellitus and Non diabetic subjects of either sex aged 18 to 60years.
2.Type II Diabetes Mellitus subjects with duration less than 5 years.
3.Subjects able to provide written informed consent.
4.Subjects without any antidiabetic medication or on metformin as monotherapy
5.Agree to follow the study prodecures and adhere to visits.
6.If female of childbearing age, willing to use an acceptable form of birth control measure, should be stable for past 3 months prior to baseline and throughout the study.
1.Subjects with deteriorating health status at the time of enrolment; rapid weight loss, terminal disease, significant chronic disease (e.g., chronic diarrhea, gastro-intestinal disease, irritable bowel syndrome).
2.Type II Diabetes Mellitus subjects with duration more than 5 years.
3.Recent blood donation (within 3 months from the date of screening).
4.Immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection).
5.Pregnant or breast feeding women.
6.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study.
7.Conditions in the opinion of the investigator make the patient unsuitable to participate in the study .
8.Any contraindication to blood sampling.
9.Subjects with history of nephropathy/Renal dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the glycemic levels ( FBG, PPBS) in type II diabetes patients and non diabetic subjects.Timepoint: 0 m, 15m, 30m,45m, 60m, 90m,120m, 150m,180m.
- Secondary Outcome Measures
Name Time Method Change in glycemic indexTimepoint: From baseline to end of study